This strategic move brings stability to Embecta, addressing challenges faced since its spin-off from Becton Dickinson & Co.
JOINT BASE SAN ANTONIO-FORT SAM HOUSTON, Texas --The Chemical and Biological Defense Auto-Injector Device, or CBD auto-injector, is something no Soldier ever wants to use on the battlefield. The ...
Medical Device Network on MSN
Embecta agrees to acquire Owen Mumford
The acquisition brings in the Aidaptus auto-injector platform and related intellectual property.
MGS says Auto-injector Reimagined drug-delivery device, which harnesses its design and moldmaking capabilities, can help ...
Calling all EpiPen users. The Food and Drug Administration (FDA) announced on Wednesday that two of the three epinephrine auto-injectors on the market are suffering a product shortage. The shortage ...
The Prefilled Auto Injectors Market is poised for robust expansion driven by escalating incidence of chronic conditions, heightened demand for self-administration therapeutics, and intensifying focus ...
Amgen, Inc.AMGN announced the launch of its Enbrel Mini with AutoTouch, a new auto injector device for Enbrel in the United States. The Enbrel Mini single-dose prefilled cartridges, used with the ...
Dublin, Nov. 10, 2020 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injector Market by Age group, Dosage, by End-user, and Geography - Global Drivers, Restraints, Opportunities, Trends, and Forecast up to ...
PARIS, Aug. 13, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved Auvi-Q (epinephrine injection, USP) for the ...
AstraZeneca announced it has received FDA approval for the self-administration of benralizumab in a prefilled, single-use auto-injector pen for patients with severe eosinophilic asthma, according to a ...
Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results